Residual Disease After Neoadjuvant Therapy: What Comes Next?

Not all patients achieve pCR — and that’s where strategy matters most.

This clip explores residual cancer burden, how it guides post-surgical decisions, and why DESTINY-Breast05 data may redefine adjuvant therapy for the highest-risk patients.